Sonnet Biotherapeutics Holdings: Post Purchase Agreement, Co Has Right From Time to Time at Option to Sell to Chardan up to Lesser of $25 Mln
Sonnet Biotherapeutics Holdings:在收购协议后,该公司有权不时选择向Chardan出售不超过2500万美元以内的较低金额
Sonnet Biotherapeutics Holdings: Post Purchase Agreement, Co Has Right From Time to Time at Option to Sell to Chardan up to Lesser of $25 Mln
Sonnet Biotherapeutics Holdings:在收购协议后,该公司有权不时选择向Chardan出售不超过2500万美元以内的较低金额
使用浏览器的分享功能,分享给你的好友吧